ANTI-ANDROGENS IN TREATMENT OF PROSTATE-CANCER - REPLY by Dalesio, O, Peto, R, Schroder, F

Androgen blockade in prostate cancer - Authors' reply by Dalesio, O, van Tinteren, H, Peto, R, Clarke, M, Schroder, F

MAXIMUM ANDROGEN BLOCKADE IN ADVANCED PROSTATE-CANCER - AN OVERVIEW OF 22 RANDOMIZED TRIALS WITH 3283 DEATHS IN 5710 PATIENTS by Dalesio, O, Vantinteren, H, Denis, L, Schroder, F, Blumenstein, B, Godwin, J, Peto, R

Online Traffic Analysis of Direct-to-Consumer Websites for Hair Loss Treatment and Characterization of Finasteride Patients on a Platform in Germany: A Potential Paradigm Shift in... by Abeck F, Hansen I, Wiesenhütter I, Schröder F, Kött J, Schneider SW, von Büren J

Get full text

Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication. by Vickers, A, Cronin, A, Roobol, M, Savage, C, Peltola, M, Pettersson, K, Scardino, P, Schröder, F, Lilja, H

A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer screening in Rotterdam, Netherlands. by Gupta, A, Roobol, M, Savage, C, Peltola, M, Pettersson, K, Scardino, P, Vickers, A, Schröder, F, Lilja, H

A four-kallikrein panel predicts prostate cancer in men with recent screening: data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam. by Vickers, A, Cronin, A, Roobol, M, Savage, C, Peltola, M, Pettersson, K, Scardino, P, Schröder, F, Lilja, H

THE P-MARK BIOBANK: A EUROPEAN MULTICENTER BIOREPOSITORY FOR PROSTATE CANCER RESEARCH by Marsden, G, Goodwin, M, Kumar, R, Bangma, C, Schroder, F, Luider, T, Bjartell, A, Lilja, H, Schalken, J, Hamdy, F, Schenk, E

Prostate specific antigen velocity does not aid prostate cancer detection in men with prior negative biopsy. by Vickers, A, Wolters, T, Savage, C, Cronin, A, O'Brien, M, Roobol, M, Aus, G, Scardino, P, Hugosson, J, Schröder, F, Lilja, H

Prostate-specific antigen velocity for early detection of prostate cancer: result from a large, representative, population-based cohort. by Vickers, A, Wolters, T, Savage, C, Cronin, A, O'Brien, M, Pettersson, K, Roobol, M, Aus, G, Scardino, P, Hugosson, J, Schröder, F, Lilja, H

A molecular movie of ultrafast singlet fission by Schnedermann, C, Alvertis, A, Wende, T, Lukman, S, Feng, J, Schröder, F, Turban, D, Wu, J, Hine, N, Greenham, N, Chin, A, Rao, A, Kukura, P, Musser, A

Innovations in serum and urine markers in prostate cancer current European research in the P-Mark project. by Gils, v, Stenman, U, Schalken, J, Schröder, F, Luider, T, Lilja, H, Bjartell, A, Hamdy, F, Pettersson, K, Bischoff, R, Takalo, H, Nilsson, O, Mulders, P, Bangma, C

Innovations in serum and urine markers in prostate cancer current European research in the P-Mark project by van Gils, M, Stenman, U, Schalken, J, Schroder, F, Luider, T, Lilja, H, Bjartell, A, Hamdy, F, Pettersson, K, Bischoff, R, Takalo, H, Nilsson, O, Mulders, R, Bangma, C

Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and... by de Koning, H, Auvinen, A, Berenguer Sanchez, A, Calais da Silva, F, Ciatto, S, Denis, L, Gohagan, J, Hakama, M, Hugosson, J, Kranse, R, Nelen, V, Prorok, P, Schröder, F

Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials by Dalesio, O, van Tinteren, H, Clarke, M, Peto, R, Schroder, F, Dechering, I, Evans, V, Godwin, J, Blumenstein, B, Crawford, E, Denis, L, Hall, R, Hill, C, Iversen, P, Shipley, W, Soloway, M, Sylvester, R, Collaborat, P

The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group. by Vickers, A, Cronin, A, Roobol, M, Hugosson, J, Jones, J, Kattan, M, Klein, E, Hamdy, F, Neal, D, Donovan, J, Parekh, D, Ankerst, D, Bartsch, G, Klocker, H, Horninger, W, Benchikh, A, Salama, G, Villers, A, Freedland, S, Moreira, D, Schröder, F, Lilja, H

Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group. by Roobol, M, Schröder, F, Hugosson, J, Jones, J, Kattan, M, Klein, E, Hamdy, F, Neal, D, Donovan, J, Parekh, D, Ankerst, D, Bartsch, G, Klocker, H, Horninger, W, Benchikh, A, Salama, G, Villers, A, Freedland, S, Moreira, D, Vickers, A, Lilja, H, Steyerberg, E

Evaluating the Prostate Cancer Prevention Trial High Grade Prostate Cancer Risk Calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative Group. by Ankerst, D, Boeck, A, Freedland, S, Jones, J, Cronin, A, Roobol, M, Hugosson, J, Kattan, M, Klein, E, Hamdy, F, Neal, D, Donovan, J, Parekh, D, Klocker, H, Horninger, W, Benchikh, A, Salama, G, Villers, A, Moreira, D, Schröder, F, Lilja, H, Vickers, A, Thompson, I

Screening and prostate-cancer mortality in a randomized European study. by Schröder, F, Hugosson, J, Roobol, M, Tammela, T, Ciatto, S, Nelen, V, Kwiatkowski, M, Lujan, M, Lilja, H, Zappa, M, Denis, L, Recker, F, Berenguer, A, Määttänen, L, Bangma, C, Aus, G, Villers, A, Rebillard, X, van der Kwast, T, Blijenberg, BG, Moss, S, de Koning, H, Auvinen, A

Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group. by Ankerst, D, Boeck, A, Freedland, S, Thompson, I, Cronin, A, Roobol, M, Hugosson, J, Stephen Jones, J, Kattan, M, Klein, E, Hamdy, F, Neal, D, Donovan, J, Parekh, D, Klocker, H, Horninger, W, Benchikh, A, Salama, G, Villers, A, Moreira, D, Schröder, F, Lilja, H, Vickers, A